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Reirradiation for Recurrent Meningioma
Purpose/Objective(s)
Management options for meningioma include observation, surgical 
resection, and radiation therapy (RT). In cases of progressive or 
recurrent disease after RT, similar options exist. The control rate 
following a second course of RT is unknown.
Material/Methods
We reviewed an institutional database of patients treated with 
stereotactic radiosurgery (SRS) or fractionated stereotactic 
radiotherapy (fSRT) for meningioma. Patients who underwent two 
or more courses of RT for disease recurrence or progression were 
identified. Clinical, treatment, and outcome data for these patients 
were recorded. Disease progression was defined as documented 
growth on follow-up imaging or additional intervention.
Results
Six-hundred-fifty-one (651) patients were treated with RT for 
meningioma from 1995 to 2009. Of those, 18 patients who underwent 
reirradiation for recurrent or progressive meningioma and follow-up 
imaging were identified. Thirteen (13) patients underwent surgical 
resection before the first course of RT, and 6 patients underwent 
surgical resection between courses of RT. Median interval between 
courses of RT was 42 months (range 3-93). Ten (10) patients were treated 
with SRS (14-18 Gy), and 8 were treated with fSRT (35.0-54.0 Gy). 
With median follow-up time of 31 months (range 2-105), 11 patients 
(61%) were found to progress after reirradiation, at a median of 10 
months (range 5-57) following completion of treatment. Kaplan-
Meier estimates of freedom from progression (FFP) at 1, 2, and 3 
years were 65%, 65%, and 49%, respectively.  
Seven patients (39%) were shown to have atypical or malignant 
histology on biopsy or surgical resection at some point in their 
treatment course. Median time to progression for these patients was 
8 months. Median time to progression has not been reached for other 
patients. FFP at 1 year for patients with atypical or malignant tumors 
was 17%, compared to 90% for grade 1/unbiopsied tumors (p<0.01).
Conclusion
Reirradiation for recurrent or progressive meningioma yields 
modest tumor control rates. Outcomes are poor in patients with 
high-grade tumors.
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